Skip to content
10-Q

Quarterly Report

NewGen BioPharma Corp.

0001640334-16-001651

← back to feed
Filed
Sep 7, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Sep 3, 2016 11.9M sh
Stockholders Equity Q3 2016 · Jul 31, 2016 −$104.64K
Stockholders Equity Q3 2016 · Oct 31, 2015 −$83.31K
Total Liabilities Q3 2016 · Jul 31, 2016 $104.64K
Total Liabilities Q3 2016 · Oct 31, 2015 $83.31K
Sga Expense Q3 2016 · Jul 31, 2016 $1K
Sga Expense Q3 2016 · Jul 31, 2016 $3.3K
Sga Expense Q3 2016 · Jul 31, 2015 $1.4K
Sga Expense Q3 2016 · Jul 31, 2015 $4.35K
Net Income Q3 2016 · Jul 31, 2016 −$4K
Net Income Q3 2016 · Jul 31, 2016 −$21.33K
Net Income Q3 2016 · Jul 31, 2015 −$4.4K
Net Income Q3 2016 · Jul 31, 2015 −$19.96K
Operating Income Q3 2016 · Jul 31, 2016 −$4K
Operating Income Q3 2016 · Jul 31, 2016 −$21.33K
Operating Income Q3 2016 · Jul 31, 2015 −$4.4K
Operating Income Q3 2016 · Jul 31, 2015 −$19.96K
Stock Issued Q3 2016 · Oct 31, 2013 2.9M sh
Stock Issued Q3 2016 · Feb 28, 2011 9M sh